House
File
383
-
EnrolledIntroduced
House
File
HOUSE
FILE
383
BY
COMMITTEE
ON
HEALTH
ANAND
ACT
RELATING
HUMAN
SERVICES
(SUCCESSOR
TO
THE
CONTROLLED
SUBSTANCE
CRYSTALLINE
POLYMORPH
PSILOCYBIN.
HF
14)
A
BILL
FOR
An
Act
relating
to
the
controlled
substance
crystalline
1
polymorph
psilocybin.
2
BE
10 unchanged paragraphs
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3
TLSB
1725HV
(1)
91
as/js
H.F.
383
Section
8 unchanged paragraphs
1.
Section
124.201,
Code
2025,
is
amended
by
adding
1
the
following
new
subsection:
2
NEW
6 unchanged paragraphs
SUBSECTION
.
5.
a.
Notwithstanding
section
124.204,
3
subsection
6 unchanged paragraphs
4,
a
drug
that
contains
the
pharmaceutical
4
composition
6 unchanged paragraphs
of
crystalline
polymorph
psilocybin,
also
known
as
5
COMP
10 unchanged paragraphs
360,
or
any
other
trade
name
approved
by
the
United
States
6
food
6 unchanged paragraphs
and
drug
administration,
shall
be
immediately
removed
7
from
7 unchanged paragraphs
schedule
I
under
section
124.204,
subsection
4,
paragraph
8
“s”
10 unchanged paragraphs
,
upon
its
approval
by
the
United
States
food
and
drug
9
administration
5 unchanged paragraphs
and
rescheduled
based
upon
the
recommendations
10
of
8 unchanged paragraphs
the
United
States
food
and
drug
administration
and
its
11
listing
7 unchanged paragraphs
in
the
federal
Controlled
Substances
Act,
21
U.S.C.
12
§812,
3 unchanged paragraphs
and
21
C.F.R.
§1308.14.
13
b.
7 unchanged paragraphs
Immediately
upon
the
rescheduling
of
the
drug
under
14
paragraph
9 unchanged paragraphs
“a”
,
it
shall
be
lawful
to
prescribe,
distribute,
and
15
market
5 unchanged paragraphs
the
pharmaceutical
composition
of
crystalline
polymorph
House
File
383,
p.
2
16
psilocybin,
9 unchanged paragraphs
also
known
as
COMP
360,
or
any
other
trade
name
17
approved
7 unchanged paragraphs
by
the
United
States
food
and
drug
administration.
______________________________
PAT
GRASSLEY
Speaker
18
EXPLANATION
19
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
20
the
explanation’s
substance
by
the
members
of
the
House
______________________________
AMY
SINCLAIR
President
general
assembly.
21
This
bill
relates
to
the
controlled
substance
crystalline
22
polymorph
psilocybin.
23
Current
law
categorizes
the
controlled
substance
psilocybin
24
as
a
schedule
I,
hallucinogenic
substance
(Code
section
25
124.201(4)(s)).
26
The
bill
provides
that
notwithstanding
Code
section
27
124.204(4),
a
drug
that
contains
the
pharmaceutical
composition
28
of
crystalline
polymorph
psilocybin
shall
be
immediately
29
removed
from
schedule
I
upon
its
approval
by
the
United
30
States
food
and
drug
administration
and
rescheduled
based
31
upon
the
recommendations
of
the
United
SenateStates
I
hereby
certify
that
food
and
drug
32
administration
and
thisits
bill
originated
listing
in
the
House
federal
Controlled
33
Substances
Act.
34
The
bill
provides
that
upon
the
rescheduling
of
psilocybin,
35
-1-
LSB
1725HV
(1)
91
as/js
1/
2
H.F.
383
it
shall
be
lawful
to
prescribe,
distribute,
and
is
known
as
House
File
383,
Ninety-first
General
Assembly.
______________________________
MEGHAN
NELSON
market
Chiefthe
Clerk
1
pharmaceutical
composition
of
crystalline
polymorph
psilocybin.
2
Current
penalties
for
the
possession
of
psilocybin
range
3
from
a
Houseserious
Approved
_______________,
2025
______________________________
KIM
REYNOLDS
Governor
misdemeanor
to
a
class
“B”
felony.
4
-2-
LSB
1725HV
(1)
91
as/js
2/
2